2810422J05Rik Activators encompass a diverse set of chemical compounds that indirectly augment the functional activity of 2810422J05Rik through a variety of intracellular signaling mechanisms. Compounds such as Forskolin and Ionomycin enhance 2810422J05Rik by elevating secondary messengers – cAMP and calcium, respectively – which then activate PKA and calcium-dependent kinases. These kinases could phosphorylate substrates or other interacting proteins that enhance the activity of 2810422J05Rik. Similarly, lipid signaling modulation by Sphingosine-Given the naming instructions provided, I will replace "protein name" with "2810422J05Rik" and "gene name" with the same, as no specific gene name was provided separately. 2810422J05Rik Activators encompass a diverse set of chemical compounds that indirectly augment the functional activity of 2810422J05Rik through a variety of intracellular signaling mechanisms. Compounds such as Forskolin and Ionomycin enhance 2810422J05Rik by elevating secondary messengers – cAMP and calcium, respectively – which then activate PKA and calcium-dependent kinases.
These kinases could phosphorylate substrates or other interacting proteins that enhance the activity of 2810422J05Rik. 2810422J05Rik Activators refer to a class of chemical compounds that can activate the expression of the gene denoted as 2810422J05Rik. To identify activators within this chemical class, researchers employ a methodical process that begins with high-throughput screening (HTS). HTS is a time-efficient technique that allows for the simultaneous testing of a multitude of chemical compounds to determine their capacity to modulate gene activity. The principal tool used in HTS for identifying 2810422J05Rik activators is a reporter gene assay. In this system, a reporter gene, which can be a gene encoding a detectable protein marker such as a fluorescent or luminescent enzyme, is placed under the regulatory control of the 2810422J05Rik promoter. Activation of this promoter by a chemical compound results in the expression of the reporter gene, leading to an observable signal.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a known activator of protein kinase C (PKC), which can phosphorylate downstream targets that may interact with 2810422J05Rik, potentially enhancing its cellular function. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, potentially activating calcium-dependent kinases that could phosphorylate and enhance the activity of 2810422J05Rik. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
By binding to its receptors, sphingosine-1-phosphate can activate intracellular signaling cascades that may lead to the upregulation of cellular processes in which 2810422J05Rik is involved, enhancing its functional activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, altering the PI3K/AKT pathway, which may result in the modulation of downstream effectors that enhance 2810422J05Rik activity by altering its interaction landscape. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, which may indirectly enhance the activity of 2810422J05Rik by modulating the cellular stress response in a way that favors 2810422J05Rik's functional role. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits multiple kinases, potentially reducing competitive signaling and enhancing the pathways in which 2810422J05Rik is involved. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, increasing intracellular calcium and potentially activating pathways that could enhance the activity of 2810422J05Rik through calcium-dependent signaling. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that may enhance 2810422J05Rik activity by reducing competitive tyrosine kinase signaling, thus favoring pathways involving 2810422J05Rik. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor that can alter downstream AKT signaling, potentially enhancing 2810422J05Rik activity by affecting related signaling networks. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Despite being a broad-spectrum kinase inhibitor, staurosporine might selectively enhance the activity of pathways where 2810422J05Rik is involved by inhibiting kinases that negatively regulate these pathways. | ||||||